0002008439-26-000005.txt : 20260715 0002008439-26-000005.hdr.sgml : 20260715 20260715124900 ACCESSION NUMBER: 0002008439-26-000005 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260715 DATE AS OF CHANGE: 20260715 EFFECTIVENESS DATE: 20260715 FILER: COMPANY DATA: COMPANY CONFORMED NAME: LYNCH REGENERATIVE MEDICINE, LLC CENTRAL INDEX KEY: 0002008439 ORGANIZATION NAME: EIN: 934863143 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-590859 FILM NUMBER: 261176805 BUSINESS ADDRESS: STREET 1: 302 INNOVATION DRIVE STREET 2: SUITE 500 CITY: FRANKLIN STATE: TN ZIP: 37067 BUSINESS PHONE: 615-649-4694 MAIL ADDRESS: STREET 1: 302 INNOVATION DRIVE STREET 2: SUITE 500 CITY: FRANKLIN STATE: TN ZIP: 37067 D 1 primary_doc.xml X0708 D LIVE 0002008439 LYNCH REGENERATIVE MEDICINE, LLC 302 INNOVATION DRIVE SUITE 500 FRANKLIN TN TENNESSEE 37067 615-649-4694 DELAWARE None None Limited Liability Company true 2023 SAMUEL LYNCH 302 INNOVATION DRIVE SUITE 500 FRANKLIN TN TENNESSEE 37067 Executive Officer Director Promoter ALLISON LYNCH 302 INNOVATION DRIVE SUITE 500 FRANKLIN TN TENNESSEE 37067 Director EARL DOUGLAS 302 INNOVATION DRIVE SUITE 500 FRANKLIN TN TENNESSEE 37067 Director TOD REED 302 INNOVATION DRIVE SUITE 500 FRANKLIN TN TENNESSEE 37067 Director ANDREA MADISON DINI 302 INNOVATION DRIVE SUITE 500 FRANKLIN TN TENNESSEE 37067 Executive Officer Other Health Care Decline to Disclose 06b false 2026-06-30 false true false 0 17500004 15000004 2500000 false 21 0 0 0 true The Issuer will compensate executive officers in the ordinary course of business. false LYNCH REGENERATIVE MEDICINE, LLC /s/ Samuel Lynch Samuel Lynch Chief Executive Officer 2026-07-15